is a hi-tech company located at Biobay in Suzhou Industrial Park (a national hi-tech park founded by Chinese and Singapore governments). Besides its research efforts for innovative drugs in oncology and cardiovascular areas, Arromax commits to the development of innovative synthetic technologies for the production of high quality generic drug APIs and their key intermediates. Arromax lays great st
resses on the R&D of new technologies and products, and closely follow the trend of pharmaceutical research. Applying the technologies of organic chemistry, medicinal chemistry, biology and computer science, Arromax is devoted to research and development of new drugs and novel synthetic methods. The core competence of Arromax development strategy is based on innovation and invention. We are working hard for the development of world pharmaceutical industry. Promoting human health, applying creativity to realize self-values and undertaking social responsibility is Arromax mission. To be a leading global platform for technological innovation and a famous brand of new drugs is Arromax vision. Keeping the spirit of "be united, striving, truth-seeking and be creative", Arromax is growing to be a new pharmaceutical hi-tech company with innovative R&D capabilities.
